We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MZZ icon
6401
ProShares UltraShort MidCap400
MZZ
$2.34M
$45K ﹤0.01%
+796
New +$48.6K
PHUN icon
6402
Phunware
PHUN
$43.6M
$45K ﹤0.01%
762
+154
+25% +$10.6K
ROSC icon
6403
Hartford Multifactor Small Cap ETF
ROSC
$62.5M
$45K ﹤0.01%
1,481
-294
-17% -$8.74K
SBB icon
6404
ProShares Short SmallCap600
SBB
$3.35M
$45K ﹤0.01%
+757
New +$47.4K
TZA icon
6405
Direxion Daily Small Cap Bear 3x ETF
TZA
$210M
$45K ﹤0.01%
16
-111
-87% -$367K
GRTX
6406
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$45K ﹤0.01%
+3,389
New +$41.3K
VRAY
6407
DELISTED
ViewRay, Inc.
VRAY
$45K ﹤0.01%
10,536
-2,589
-20% -$8.37K
EXIV
6408
DELISTED
VelocityShares 1x Daily Inverse VSTOXX Futures ETN
EXIV
$45K ﹤0.01%
1,028
+3
+0.3% +$118
IHTA
6409
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
$45K ﹤0.01%
4,314
+2,827
+190% +$29.5K
MLTI
6410
DELISTED
Credit Suisse X-Links Multi-Asset High Income ETN
MLTI
$45K ﹤0.01%
1,582
-578
-27% -$16K
BRFS
6411
CALL
DELISTED
BRF SA
BRFS
$44K ﹤0.01%
5,000
JCPB icon
6412
JPMorgan Core Plus Bond ETF
JCPB
$14B
$44K ﹤0.01%
+830
New +$44.1K
METC icon
6413
Ramaco Resources Class A
METC
$649M
$44K ﹤0.01%
12,573
+5,520
+78% +$18.5K
ROBT icon
6414
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$774M
$44K ﹤0.01%
+1,284
New +$42.1K
SNDX icon
6415
CALL
Syndax Pharmaceuticals
SNDX
$1.82B
$44K ﹤0.01%
+5,000
New +$36.7K
TECS icon
6416
Direxion Daily Technology Bear 3x ETF
TECS
$55.6M
$44K ﹤0.01%
+1
New +$90.3K
TZOO icon
6417
Travelzoo
TZOO
$75.4M
$44K ﹤0.01%
+4,107
New +$42.6K
VEGA icon
6418
AdvisorShares STAR Global Buy-Write ETF
VEGA
$91.2M
$44K ﹤0.01%
1,279
+164
+15% +$5.45K
GSV
6419
DELISTED
Gold Standard Ventures Corp.
GSV
$44K ﹤0.01%
50,794
-29,041
-36% -$21.8K
ASHX
6420
DELISTED
Xtrackers MSCI China A Inclusion Equity ETF
ASHX
$44K ﹤0.01%
2,103
+90
+4% +$1.81K
JHME
6421
DELISTED
John Hancock Multifactor Energy ETF
JHME
$44K ﹤0.01%
1,863
+478
+35% +$11K
AUTL
6422
Autolus Therapeutics
AUTL
$562M
$43K ﹤0.01%
3,233
-2
-0.1% -$26
CARZ icon
6423
First Trust Exchange-Traded Fund II First Trust S-Network Future Vehicles & Technology ETF
CARZ
$48.4M
$43K ﹤0.01%
1,291
-748
-37% -$25.1K
FCO
6424
DELISTED
abrdn Global Income Fund
FCO
$43K ﹤0.01%
5,293
-2,196
-29% -$17.7K
NDAQ icon
6425
PUT
Nasdaq
NDAQ
$52.9B
$43K ﹤0.01%
+1,200
New +$40.9K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.